The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Bevacizumab     Injury: Hypophosphataemia     Quarter: 2016Q3

Total Records: 28     Number of Pages: 2

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127451141 Bevacizumab Hypophosphataemia ROCHE 60.00 YR F 0 20160915 US
127555931 Bevacizumab Hypophosphataemia ROCHE 61.00 YR F 61 KG 20160916 US
127580821 Bevacizumab Hypophosphataemia ROCHE 40.00 YR M 0 20160919 US
127873111 Bevacizumab Hypophosphataemia ROCHE 63.00 YR F 99 KG 20160927 US
127905841 Bevacizumab Hypophosphataemia ROCHE 56.00 YR F 69 KG 20160929 US
127911311 Bevacizumab Hypophosphataemia ROCHE 0.00 F 63 KG 20160929 US
127911541 Bevacizumab Hypophosphataemia ROCHE 63.00 YR F 69 KG 20160929 US
127975691 Bevacizumab Hypophosphataemia ROCHE 75.04 YR F 71 KG 20160930 US

Total Records: 28     Number of Pages: 2